American Nutriceuticals - A0201 - Natura, 201-Digestive

120 Vegicaps Natura 201 (Compound Xiangfu Granules) has been applied in the clinical treatment of more than 80,000 patients with liver cancer and has shown marked efficacy. Liver cancer refers to carcinogenesis that occurs in liver cells and the bile duct epithelial cells inside the liver. It is one of the most commonly found malignant cancers in humans. In a clinical analysis using 800 of these patients, the effect of Natura 201 was examined. The vast majority were diagnosed as having liver cancer by the relevant examinations using Western medicine. Of the 800 participants, the number of basically cured was 98 cases (12.3%) with survival for at least 5 years; 228 cases (28.5%) were markedly effective; 306 cases (38.2%) were effective; 168 cases (21.0%) were ineffective; for a total effectiveness rate of 79%. When Natura 201 is used to treat liver cancer, there are no toxic adverse reactions, a marked effect in inhibiting the growth of tumor cells and an improvement of immunological function and quality of life. The below clinical synopsis reflects only kidney cancer patients, but the 301 formula has also been used successfully for other urinary system cancers such as penis, cervix and bladder.